Utah Medical Products, Inc.
UTMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $14 | $17 | $16 | $15 |
| Dep. & Amort. | $3 | $6 | $7 | $7 |
| Deferred Tax | $0 | -$1 | -$0 | -$0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$2 | -$0 | -$2 | -$1 |
| Other Non-Cash | -$0 | -$0 | $0 | $0 |
| Operating Cash Flow | $15 | $22 | $21 | $21 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$1 | -$1 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$0 | -$1 | -$1 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $1 |
| Stock Repurch. | -$20 | -$2 | -$2 | -$7 |
| Dividends Paid | -$4 | -$4 | -$3 | -$11 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | -$24 | -$4 | -$5 | -$11 |
| Forex Effect | -$1 | $0 | -$1 | -$0 |
| Net Chg. in Cash | -$10 | $18 | $14 | $9 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $93 | $75 | $61 | $52 |
| End Cash | $83 | $93 | $75 | $61 |
| Free Cash Flow | $15 | $22 | $20 | $21 |